CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma-Reference-Cited by-同舟云学术

CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma

Published:2022-12 Issue:12 Volume:35 Page:2002-2010
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

Brunac Anne-Cécile^ORCID,Fourquet Joanna,Perot Gaëlle,Jaffrelot Marion,Meilleroux Julie,Danjoux Marie,Filleron Thomas,Nicolaï Vincent,Guimbaud Rosine,Icher Samira,Farés Nadim,Selves Janick,Chibon Frédéric^ORCID

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-022-01166-9.pdf

Reference31 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Colorectal cancer statistics, 2020;Siegel;CA A Cancer J Clin,2020

3. TNM classification of malignant tumours. (John Wiley & Sons, Inc, 2017).

4. Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox;Kim;J Surg Oncol,2019

5. Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial;André;J Clin Oncol,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic subtyping of gastrointestinal malignancies;Trends in Cancer;2024-09

2. The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients;Cancer & Metabolism;2024-07-11

3. Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges;Cancer Medicine;2024-07

4. Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion;Translational Oncology;2024-06

5. Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine;Cancers;2024-01-23